miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1
published in: Molecular Therapy. Methods & Clinical Development
date of publication: 2021-09-14
Cites articles 1
Date
Title
Article - wd:Q112288943
Article - wd:Q112288943